Company Analysis

Maravai LifeSciences Holdings, Inc. (MRVI)

Nasdaq: MRVI · Pharmaceutical Preparations · San Diego, CA · filing with the SEC since 2020
Grade3.8
◀ Past 3.9● Present 4.4▶ Future 2.9

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts in thousands. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019
Report filedFeb 26, 2026Mar 18, 2025Feb 29, 2024Feb 28, 2023Mar 1, 2022Mar 22, 2021·
Revenue185,743259,185288,945883,001799,240284,098143,140
Cost of revenue151,753150,876148,743168,957140,56179,64966,849
Gross profit33,990108,309140,202····
Research and development17,40219,22117,28018,36915,2199,3043,627
Selling, general and administrative145,118161,771151,390129,259100,06494,24548,354
Total costs and expenses249,256343,926r171,850r308,785244,595164,196119,152
Operating income-215,266-235,617-31,648574,216554,645119,90223,988
Interest expense26,99247,70045,89220,41430,26030,74029,959
Interest and investment income11,43627,40327,7272,33800·
Other income (expense), net-4,152-2,341-1,337-358279126118
Income before income taxes-234,974-261,482617,736551,472530,76581,696-5,853
Income tax expense-4,212-1,860756,11160,80961,5152,880-652
Net income including non-controlling interests-230,762-259,622-138,375490,663469,25078,816-5,201
Net income to non-controlling interests-99,989-114,776-19,346270,458287,213-10,156-731
Net income-130,773-144,846-119,029220,205182,03788,972-4,470
Net income to common shareholders-130,773-144,846-119,029220,205182,03776,888-8,486
Earnings per share, basic-0.90-1.05-0.901.671.597.43-0.03
Earnings per share, diluted-0.90-1.05-0.901.671.562.36-0.03
Weighted average shares, basic144,360137,906131,919131,545114,79110,351253,917
Weighted average shares, diluted144,360137,906131,919255,323257,80328,908253,917
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfRevenue
Gross profit revenue less the cost of what it soldus-gaap:GrossProfit
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense
Total costs and expenses every operating cost, the cost of revenue includedus-gaap:CostsAndExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpenseNonoperating
us-gaap:InterestExpense
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss
Net income to non-controlling interests the share that belongs to minority holdersus-gaap:NetIncomeLossAttributableToNoncontrollingInterest
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
SI Assistanton MRVI · research, not advice